News from cardiodx, inc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Nov 25, 2013, 08:30 ET Results from REGISTRY 1 Study Confirm Clinical Utility of Corus® CAD Genomic Test in Optimizing Care in Elderly Patients Presenting to the Primary Care Clinician with Symptoms Suggestive of Obstructive Coronary Artery Disease

 CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, announced results from a multi-center, real-world...


Nov 18, 2013, 11:45 ET New Data Presented at the AHA Scientific Sessions Highlight the Clinical Utility of the Corus CAD Gene Expression Test in Women and Demonstrate that the Corus CAD Score Correlates with Cardiovascular Outcomes

 CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, today announced results from two studies reinforcing...


Oct 21, 2013, 08:30 ET CardioDx Real-World Registry Study Shows Use of the Corus® CAD Gene Expression Test Helps Reduce Unnecessary Patient Referrals for Cardiac Testing

 CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, today announced results of a multi-center,...


Oct 11, 2013, 16:38 ET CardioDx Files Registration Statement for Proposed Initial Public Offering

 CardioDx, Inc. announced today that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission...


Oct 10, 2013, 08:30 ET New Data Highlight Value of Corus® CAD in Reducing Unnecessary Cardiac Testing and Costs for Women with Symptoms Suggestive of Obstructive Coronary Artery Disease

 CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, today announced results of two studies indicating...


Sep 03, 2013, 08:30 ET IMPACT-CARD Trial Data Presented at the 2013 European Society of Cardiology Congress Demonstrate the Value of Corus® CAD as a Decision-Making Tool for Cardiologists

 CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, today announced the presentation of results from the...


Aug 26, 2013, 14:23 ET Review Published in PLOS Currents Highlights Overall Evidence for the Use of Corus® CAD to Evaluate Obstructive Coronary Artery Disease

 CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, today announced the publication of a comprehensive...


May 30, 2013, 08:30 ET CardioDx to Present at the Jefferies 2013 Global Healthcare Conference

 CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced that the company will present at the Jefferies...


May 20, 2013, 08:30 ET CardioDx Announces Publication of the IMPACT-CARD Trial Demonstrating Use of Corus® CAD Test Influenced Cardiologists' Clinical Management of Patients with Symptoms Suggestive of Obstructive Coronary Artery Disease

 CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced the publication of the IMPACT-CARD...


May 17, 2013, 11:00 ET CardioDx Announces New Data Demonstrating Use of Corus® CAD in the Primary Care Setting for Evaluation of Symptomatic Patients with Suspected CAD Influences Clinical Decision Making

CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced results of a clinical utility study of the...


May 09, 2013, 08:30 ET CardioDx Receives College of American Pathologists (CAP) Accreditation

 CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced its onsite clinical laboratory has received...


Apr 25, 2013, 17:02 ET CardioDx and Core Diagnostics India Announce Exclusive Corus® CAD Product Marketing and Sales Agreement

 CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced it has entered into an agreement granting to...


Apr 23, 2013, 08:30 ET CardioDx to Present at the 12th Annual Needham Healthcare Conference

CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced that the company will present at the 12th Annual...


Mar 25, 2013, 08:30 ET Study Finds Corus CAD to Be More Accurate in Excluding the Diagnosis of Obstructive Coronary Artery Disease in Women than Standard Diagnostic Methods

 CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced data demonstrating that Corus® CAD, the...


Mar 11, 2013, 08:30 ET Data Presented at ACC 2013 Confirms Use of Corus® CAD in Women with Suspected Obstructive Coronary Artery Disease Influences Patient Management Decisions

 CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced results of a prospective study that evaluated...


Mar 04, 2013, 08:30 ET CardioDx to Present Sex-Specific Data on Value of Corus® CAD in Influencing Diagnostic Strategy for Women with Suspected Obstructive Coronary Artery Disease at the 2013 American College of Cardiology Meeting

 CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, announced that clinical data from studies of Corus® CAD,...


Feb 25, 2013, 08:30 ET CardioDx to Present at Cowen and Company 33rd Annual Healthcare Conference

 CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced that the company will present at the Cowen and...


Feb 19, 2013, 08:30 ET CardioDx Announces Publication of COMPASS Study Demonstrating the Corus® CAD Test Outperforms Myocardial Perfusion Imaging in Overall Diagnostic Accuracy for Obstructive Coronary Artery Disease

 CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced the publication of the COMPASS (Coronary...